----
Q2 FY2026 EarningsQ2 FY2026 results showed a mix of performance against consensus: Revenue of $19.15B missed the $19.55B consensus, and GAAP EPS of $1.09 was significantly below the $2.13 expected due to $1.2B in investment and derivative losses. However, Normalized EPS of $2.43 beat the $2.29 consensus by 6.1%, driven by a 25% adjusted earnings jump in Group Benefits and strong variable investment income in Asia. While GAAP profitability was pressured by market volatility, core business momentum remains robust with Adjusted ROE at 17.0%.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: MetLife(MET) the Revenue is 19.08 B (+6.44%), Miss estimate;the EBIT is 2.386 B (+13.51%), Beat estimate;the EPS is 1.09 (+5.83%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
19.07B6.44%
19.55B9.10%
-0.48B2.66%
EBITExceed expectations
2.39B13.51%
2.20B4.47%
+0.19B9.04%
EPSMiss expectations
1.095.83%
2.1338107.17%
-1.0438101.34%
Upcoming earnings report - Q3 FY2026
Available dateNov 4, 2026
Estimate Revenue$19.97 B
Estimate EBIT$2.739 B
Estimate EPS$2.6146
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
